GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0022604 | Colorectum | AD | regulation of cell morphogenesis | 109/3918 | 309/18723 | 3.08e-09 | 2.07e-07 | 109 |
GO:0034329 | Colorectum | AD | cell junction assembly | 136/3918 | 420/18723 | 2.02e-08 | 1.15e-06 | 136 |
GO:0016311 | Colorectum | AD | dephosphorylation | 123/3918 | 417/18723 | 1.84e-05 | 3.82e-04 | 123 |
GO:0006470 | Colorectum | AD | protein dephosphorylation | 88/3918 | 281/18723 | 2.56e-05 | 4.89e-04 | 88 |
GO:0010975 | Colorectum | AD | regulation of neuron projection development | 129/3918 | 445/18723 | 2.88e-05 | 5.37e-04 | 129 |
GO:0031346 | Colorectum | AD | positive regulation of cell projection organization | 104/3918 | 353/18723 | 8.26e-05 | 1.30e-03 | 104 |
GO:0071709 | Colorectum | AD | membrane assembly | 22/3918 | 50/18723 | 2.00e-04 | 2.66e-03 | 22 |
GO:0010769 | Colorectum | AD | regulation of cell morphogenesis involved in differentiation | 35/3918 | 96/18723 | 3.26e-04 | 3.85e-03 | 35 |
GO:0010770 | Colorectum | AD | positive regulation of cell morphogenesis involved in differentiation | 30/3918 | 79/18723 | 3.81e-04 | 4.38e-03 | 30 |
GO:0010720 | Colorectum | AD | positive regulation of cell development | 87/3918 | 298/18723 | 4.17e-04 | 4.71e-03 | 87 |
GO:0044091 | Colorectum | AD | membrane biogenesis | 22/3918 | 55/18723 | 9.88e-04 | 9.28e-03 | 22 |
GO:1901888 | Colorectum | AD | regulation of cell junction assembly | 61/3918 | 204/18723 | 1.50e-03 | 1.27e-02 | 61 |
GO:0050767 | Colorectum | AD | regulation of neurogenesis | 99/3918 | 364/18723 | 2.35e-03 | 1.82e-02 | 99 |
GO:0099173 | Colorectum | AD | postsynapse organization | 51/3918 | 168/18723 | 2.47e-03 | 1.90e-02 | 51 |
GO:0016358 | Colorectum | AD | dendrite development | 69/3918 | 243/18723 | 3.32e-03 | 2.42e-02 | 69 |
GO:0050808 | Colorectum | AD | synapse organization | 112/3918 | 426/18723 | 4.25e-03 | 2.92e-02 | 112 |
GO:0050807 | Colorectum | AD | regulation of synapse organization | 60/3918 | 211/18723 | 5.67e-03 | 3.64e-02 | 60 |
GO:00226041 | Colorectum | SER | regulation of cell morphogenesis | 89/2897 | 309/18723 | 1.51e-09 | 1.52e-07 | 89 |
GO:00343291 | Colorectum | SER | cell junction assembly | 100/2897 | 420/18723 | 4.23e-06 | 1.61e-04 | 100 |
GO:00717091 | Colorectum | SER | membrane assembly | 20/2897 | 50/18723 | 2.45e-05 | 6.84e-04 | 20 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PTPRD | SNV | Missense_Mutation | rs764400127 | c.1292N>T | p.Ser431Leu | p.S431L | P23468 | protein_coding | deleterious(0.01) | possibly_damaging(0.523) | TCGA-EY-A1GI-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PTPRD | SNV | Missense_Mutation | | c.2969N>G | p.Tyr990Cys | p.Y990C | P23468 | protein_coding | deleterious(0) | possibly_damaging(0.726) | TCGA-EY-A2OM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | taxol | SD |
PTPRD | SNV | Missense_Mutation | novel | c.272N>A | p.Arg91Lys | p.R91K | P23468 | protein_coding | tolerated(0.25) | benign(0.192) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PTPRD | SNV | Missense_Mutation | rs763867237 | c.2584N>T | p.Arg862Cys | p.R862C | P23468 | protein_coding | deleterious(0.01) | benign(0.189) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
PTPRD | SNV | Missense_Mutation | rs771630160 | c.1604N>G | p.Ser535Cys | p.S535C | P23468 | protein_coding | deleterious(0) | probably_damaging(0.99) | TCGA-PG-A914-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PTPRD | SNV | Missense_Mutation | | c.608N>C | p.Gly203Ala | p.G203A | P23468 | protein_coding | tolerated(0.24) | probably_damaging(0.982) | TCGA-PG-A915-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PTPRD | SNV | Missense_Mutation | novel | c.3126N>T | p.Glu1042Asp | p.E1042D | P23468 | protein_coding | tolerated(0.83) | benign(0.003) | TCGA-QF-A5YS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
PTPRD | SNV | Missense_Mutation | | c.3157N>A | p.Leu1053Ile | p.L1053I | P23468 | protein_coding | tolerated(0.21) | benign(0.005) | TCGA-QS-A5YQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
PTPRD | insertion | In_Frame_Ins | novel | c.987_988insAAGTTGCCAATA | p.Pro329_Val330insLysLeuProIle | p.P329_V330insKLPI | P23468 | protein_coding | | | TCGA-BG-A0MS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
PTPRD | insertion | In_Frame_Ins | novel | c.3880_3881insACTTAATTTCTTTTCAGACTTTTGCTT | p.Arg1294delinsAsnLeuIleSerPheGlnThrPheAlaTrp | p.R1294delinsNLISFQTFAW | P23468 | protein_coding | | | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | US9340574, 7 | | |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | pioglitazone | PIOGLITAZONE | |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | verapamil | VERAPAMIL | 26425837 |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | CIXUTUMUMAB | CIXUTUMUMAB | 23800680 |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | trandolapril | TRANDOLAPRIL | 26425837 |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | JSI-124 | | 26267899 |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | TEPROTUMUMAB | TEPROTUMUMAB | 23800680 |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | inhibitor | 381118819 | | |
5789 | PTPRD | PROTEIN PHOSPHATASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | Antihypertensives | | |